This document discusses nanomedicine and various nanoscale structures that can be used for medical applications. It begins by explaining how nanotechnology allows analysis and repair of the human body at the molecular level. It then describes various nanoscale structures like liposomes, dendrimers, carbon nanotubes, quantum dots, mesoporous silica nanoparticles and their properties. These nanoparticles can be used for targeted drug delivery, imaging and diagnosis. The document also discusses some current and potential applications of these nanotechnologies in areas like cancer treatment, biomolecular sensing and gene therapy.
Nanomaterials in biomedical applicationsumeet sharma
An introduction to emerging technology in medicinal science, "nanodrugs" a fruitful combination of nano-science and medical science. In this presentation, use of nano shells for delivery of drugs to targeted cancer cells has been explained. along with In Vivo and In Vitro studies on use of nanomaterials for biomedical application. For any information please feel free to contact me or refer to the references.
Nanomaterials in biomedical applicationsumeet sharma
An introduction to emerging technology in medicinal science, "nanodrugs" a fruitful combination of nano-science and medical science. In this presentation, use of nano shells for delivery of drugs to targeted cancer cells has been explained. along with In Vivo and In Vitro studies on use of nanomaterials for biomedical application. For any information please feel free to contact me or refer to the references.
Detailed idea on nanotechnology, nanomedicine, types, uses, pharmacotherapy, and future prospects of the nanotechnology. Drug delivery systems, Pharmacokinetics and pharmacodynamics of the nanoparticles are dealt in detail
THE FUTURE OF NANOMEDINE
Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter).
Detailed idea on nanotechnology, nanomedicine, types, uses, pharmacotherapy, and future prospects of the nanotechnology. Drug delivery systems, Pharmacokinetics and pharmacodynamics of the nanoparticles are dealt in detail
THE FUTURE OF NANOMEDINE
Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter).
Advances in integrative nanomedicine for improving infectious disease treatme...home
Nanomedicine is integrative, blending modern technology with natural products to reduce toxicity and support immune function. Nanomedicine using traditional agents from alternative systems of medicine can facilitate progress in integrative public health approaches to infectious diseases.
What process is used to obtain cells from bone marrow and normal peripheral blood?
What is the best cell counting and viability method for primary cells?
AllCells, your primary cells research partner, and Nexcelom Bioscience, your cell counting experts, have joined together in an exclusive collaboration to host a free webinar to help educate researchers and present data from their own experiences.
NEURODEGENERATION & NEUROPROTECTION-AN AYURVEDIC PERSPECTIVE.
WHAT AYURVEDA CAN OFFER BOTH IN PREVENTION & TREATMENT.FAMOUS PEOPLE SUFFERING FROM NEURODEGENERATION.MANDUKPARNI,SHANKHAPUSPI,POMGRENATE,ASWAGANDHA.BUDDHIBHRANSHA.NILANJAN DATTA.ROGNIDAN.PARKINSON,MULTIPLE SCLEROSIS,HUNTINGTONS CHOREA,ALZHEIMERS IN AYURVEDA TREATMENT.THANK YOU.ACKNOWLEDGEMENTS.DR.B.C.JANA.BHU.IPGAER AT SVSP,KOLKATA.BHU.
In recent years there has been ever increasing activity and excitement within the scientific and engineering communities, driven heavily by government investment, about engineered nanotechnology applications.
The purpose of this primer is to provide some basic information about engineered nanomaterials so that you will be better informed, understand the new 'jargon' and appreciate some of the potential new applications of these materials. in addition, understanding the wide range and types of measurements needed to characterize these nanomaterials along with what solutions PerkinElmer has to support customer working in this field are outlined.
chaminaameen@gmail.com
Amina Ameen
Ask me for any other help for PowerPoint slides on my email I'd. I will love to help you in your PowerPoint assignments.
Thanks.
Contents: Intro to nanotach, nanomaterials, nanomedicine, timeline of nanomedicine, properties of nanomaterials, and applications of nanoparticles in medicine
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
UiPath Test Automation using UiPath Test Suite series, part 4DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap.
The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies.
Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques
What will you get from this session?
1. Insights into SAP testing best practices
2. Heatmap utilization for testing
3. Optimization of testing processes
4. Demo
Topics covered:
Execution from the test manager
Orchestrator execution result
Defect reporting
SAP heatmap example with demo
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Ramesh Iyer
In today's fast-changing business world, Companies that adapt and embrace new ideas often need help to keep up with the competition. However, fostering a culture of innovation takes much work. It takes vision, leadership and willingness to take risks in the right proportion. Sachin Dev Duggal, co-founder of Builder.ai, has perfected the art of this balance, creating a company culture where creativity and growth are nurtured at each stage.
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualityInflectra
In this insightful webinar, Inflectra explores how artificial intelligence (AI) is transforming software development and testing. Discover how AI-powered tools are revolutionizing every stage of the software development lifecycle (SDLC), from design and prototyping to testing, deployment, and monitoring.
Learn about:
• The Future of Testing: How AI is shifting testing towards verification, analysis, and higher-level skills, while reducing repetitive tasks.
• Test Automation: How AI-powered test case generation, optimization, and self-healing tests are making testing more efficient and effective.
• Visual Testing: Explore the emerging capabilities of AI in visual testing and how it's set to revolutionize UI verification.
• Inflectra's AI Solutions: See demonstrations of Inflectra's cutting-edge AI tools like the ChatGPT plugin and Azure Open AI platform, designed to streamline your testing process.
Whether you're a developer, tester, or QA professional, this webinar will give you valuable insights into how AI is shaping the future of software delivery.
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Jeffrey Haguewood
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on the notifications, alerts, and approval requests using Slack for Bonterra Impact Management. The solutions covered in this webinar can also be deployed for Microsoft Teams.
Interested in deploying notification automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
2. Premises
• Since the human body is basically an extremely complex
system of interacting molecules (i.e., a molecular machine),
the technology required to truly understand and repair the
body is the molecular machine technology :
NANOTECHNOLOGY
• A natural consequence of this level of technology will be the
ability to analyze and repair the human body as completely
and effectively as we can repair any conventional machine
today.
4. Feynman: "There is plenty of room at the
bottom"
•
Seminal speech on December
1959 at CalTech
•
" Why can’t be compress 24
volumes of Encyclopedia
Britannica on a pin head ?“
•
" The biological example of writing
information on a small scale has
inspired me to think of something
that should be possible "
•
In 1990, IBM scientists wrote the
logo IBM using 35 xenon atoms on
nickel.
7. E.C.-ETP
“Nanomedicine, is defined as the application of
nanotechnology to achieve breakthroughs in
healthcare. It exploits the improved and often novel
physical, chemical and biological properties of
materials at the nanometer scale. Nanomedicine
has the potential to enable early detection and
prevention,
and
to
essentially
improve
diagnosis, treatment and follow-up of diseases.
……………………….
Diagnostics,
targeted
drug
delivery
and
regenerative medicine
constitute the core
disciplines of nanomedicine.”
8. Nanomedicine:
European Science Foundation (ESF)
“The field of Nanomedicine is the
science and technology of
diagnosing, treating and
preventing disease and traumatic
injury, of relieving pain, and of
preserving and improving human
health, using molecular tools and
molecular knowledge of the
human body. It embraces subdisciplines which are in many ways
overlapping and are underpinned
by common technical issues.”
9. The numbers of nanomedicine
The total market for
nanobiotechnology products is
$19.3 billion in 2010 and is
growing at a compound annual
growth rate (CAGR) of 9% to reach
a forecasted market size of $29.7
billion by 2015.
10. Number of publications containing “nanoparticles” in Medline
14000
12000
10000
8000
6000
4000
2000
0
1990 1995 1999 2001 2003 2005 2007 2009 2011
13. Topics in nanomedicine
• Therapy:
Drug Delivery: Use nanodevices specifically
targeted to cells, to guide delivery of drugs,
proteins and genes
Drug targeting : Whole body, cellular ,
subcellular delivery
Drug discovery : Novel bioactives and
delivery systems
14. Topics in nanomedicine
• Diagnosis:
Prevention and Early Detection of diseases: Use
nanodevices to detect specific changes in diseased
cells and organism.
16. Why Nanoparticles
1) Drugs, contrast
agents, paramagnetic or
radiolabeled probes can be
vehiculated by NPs
2) NPs can be multi-functionalized
to confer differents features on
them
17. • Targeting: nanoparticles control over
delivery.
• Drugs are concentrated to target. Less
systemic toxicity.
• Less drug is necessary
• Drugs are protected inside NPs and are not
degraded. Longer halflife
19. An ideal Multi-functional nanoparticle vector
Anticorpo
Polietilenglicol
Evita che NP venga
(PEG)
digerita nei lisosomi
Indirizza la NP verso un
antigene specifico sulla la NP venga
Evita che
cellula da colpire
rimossa dal circolo
Tat peptide
Determina Fusione e
Probe magnetico
ingresso della NP nella
cellula
Permette imaging
tramite MRI
Farmaco
20.
21. Examples of nanoparticulate carriers
+
+ +
+
+
+
LIPOSOME
S
DENDRIMER
S
SILICA NP
SOLID‐LIPID
NP
POLYMERIC
NP
QUANTUM DOTS
MICELLES
POLYMERIC MICELLE
GOLD NP
+
+
+ ++
+
LIPOPLEX
NANOTUBES
MAGNETIC
23. What are Carbon Nanotubes?
Carbon nanotubes are
hexagonally shaped
arrangements of carbon
atoms that have been
rolled into tubes.
24.
25. Nanotubes are members of the
fullerene structural family, which
also includes the spherical
buckyballs. The ends of a
nanotube might be capped with a
hemisphere of the buckyball
structure. Their name is derived
from their size, since the diameter
of a nanotube is on the order of a
few nanometers, while they can be
up to 18 centimeters in length (as
of 2010).
Nanotubes are categorized as
single-walled nanotubes (SWNTs)
and
multi-walled
nanotubes
(MWNTs)
Human hair fragment
(the purplish thing) on
top of a network of
single-walled carbon
nanotubes
27. • Single-walled nanotubes
are an important variety
of
carbon
nanotube
because they exhibit
electric properties that
are not shared by the
multi-walled
carbon
nanotube
(MWNT)
variants.One
useful
application of SWNTs is
in the development of the
first intramolecular field
effect transistors (FET).
• (Used for
nanobiosensors).
Armchair (n,n)
28. •
•
•
Multi-walled nanotubes
(MWNT) consist of multiple
rolled layers (concentric tubes)
of graphite.
In the Russian Doll model,
sheets of graphite are arranged
in concentric cylinders, e.g. a
(0,8) single-walled nanotube
(SWNT) within a larger (0,10)
single-walled nanotube.
In the Parchment model, a
single sheet of graphite is rolled
in around itself, resembling a
scroll of parchment or a rolled
newspaper. The interlayer
distance in multi-walled
nanotubes is close to the
distance between graphene
layers in graphite,
approximately 3.4 Å.
Multi-walled
29. Properties of Carbon
Nanotubes
Nanotubes have a very broad range of
electronic, thermal, and structural properties that
change depending on diameter, length. They
exhibit extraordinary strength and unique electrical
properties, and are efficient conductors of heat.
30. •
Carbon nanotubes are the strongest
and stiffest materials yet discovered in
terms of tensile strength and elastic
modulus respectively. This strength
results from the covalent sp2 bonds
formed between the individual carbon
atoms. In 2000, a multi-walled carbon
nanotube was tested to have a tensile
strength of 63 gigapascals (GPa).
(This, for illustration, translates into the
ability to endure tension of a weight
equivalent to 6422 kg on a cable with
cross-section of 1 mm2.) Since carbon
nanotubes have a low density for a
solid of 1.3 to 1.4 g·cm−3, its specific
strength of up to 48,000 kN·m·kg−1 is
the best of known materials, compared
to high-carbon steel's 154 kN·m·kg−1.
Strength
32. Thermal property
•
All nanotubes are expected to be very good
thermal conductors along the tube,
exhibiting a property known as "ballistic
conduction," but good insulators laterally to
the tube axis.
33. Defects
•
As with any material, the existence of a
crystallographic defect affects the material
properties. Defects can occur in the form of
atomic vacancies. High levels of such defects can
lower the tensile strength by up to 85%.
Crystallographic defects also affect the tube's
electrical properties. A common result is lowered
conductivity through the defective region of the
tube.
34. Natural, incidental, and
controlled flame environments
•
Fullerenes and carbon nanotubes are not
necessarily products of high-tech laboratories;
they are commonly formed in such places as
ordinary
flames,produced
by
burning
methane,ethylene,and benzene,and they have
been found in soot from both indoor and outdoor
air. However, these naturally occurring varieties
can be highly irregular in size and quality
because the environment in which they are
produced is often highly uncontrolled.
36. In electrical circuits
•
Nanotube based transistors
have been made that operate
at room temperature and that
are capable of digital switching
using a single electron.The first
nanotube integrated memory
circuit was made in 2004.
Nanotube Transistor
37. Proposed as a vessel for transporting drugs
into the body. The drug can be attached to the side or trailed
behind, or the drug can actually be placed inside the
nanotube
Nanotube
Nanocap
40. final usage, however, may be limited by
their potential toxicity.
Under some conditions, nanotubes can cross
membrane barriers and can induce harmful
effects: inflammation, epithelioid granulomas
(microscopic
nodules),
fibrosis,and
biochemical/toxicological changes in the lungs.
Determining the toxicity of carbon nanotubes
has been one of the most pressing questions
in
nanotechnology.Unfortunately
such
research has only just begun and the data are
still fragmentary and subject to criticism.
Preliminary results highlight the difficulties in
evaluating the toxicity of this heterogeneous
material. Parameters such as structure, size
distribution, surface area, surface chemistry,
surface charge, and agglomeration state as
well as purity of the samples, have
considerable impact on the reactivity of carbon
nanotubes..
Their
Toxicity
44. gold nanoparticles (1-20 nm) are produced by reduction
of chloroauric acid (H[AuCl4]),
To the rapidly-stirred boiling HAuCl4
solution, quickly add 2 mL of a 1% solution of
trisodium citrate dihydrate, Na3C6H5O7.2H2O.
The gold sol gradually forms as the citrate
reduces the gold(III). Remove from heat when
the solution has turned deep red or 10 minutes
has elapsed.
45.
46. In cancer research, colloidal gold can be used to target
tumors and provide detection using SERS (Surface
Enhanced Raman Spectroscopy) in vivo.
They are being investigated as photothermal converters
of near infrared light for in-vivo applications, as ablation
components for cancer, and other targets since near
infrared light transmits readily through human skin and
tissue
53. HYDROGELS
Polymers or co-polymers (e.g. acrylamide and acrylic acid) create
water-impregnated nanoparticles with pores of well-defined size.
Water flows freely into these particles, carrying proteins and other small
molecules into the polymer matrix.
By controlling the pore size, huge proteins such as albumin and
immunoglobulin are excluded while smaller peptides and other
molecules are allowed.
The polymeric component acts as a negatively
charged "bait" that attracts positively
charged proteins, improving the particles'
performance.
55. Mesoporous silica particles: nano-sized spheres filled with a regular
arrangement of pores with controllable pore size from 3 to 15nm and outer
diameter from 20nm to 1000 nm .
The large surface area of the pores allows the particles to be filled with a
drug or with a fluorescent dye that would normally be unable to pass
through cell walls. The MSN material is then capped off with a molecule that
is compatible with the target cells. When are added to a cell culture, they
carry the drug across the cell membrane.
These particles are optically transparent,
so a dye can be seen through the silica walls.
The types of molecules that
are grafted to the outside will control what
kinds of biomolecules are allowed inside
the particles to interact with the dye.
EM
57. A quantum dot is a semiconductor whose excitons are
confined in all three spatial dimensions.
An immediate optical feature of colloidal quantum
dots is their coloration
First attempts have been made to use quantum dots
for tumor targeting under in vivo conditions.
Generically toxic
58. Quantum Dot Properties
High quantum yield compared to common fluorescent dyes
Broadband absorption: light that has a shorter wavelength than
the emission maximum wavelength can be absorbed, peak
emission wavelength is independent of excitation source
Tunable and narrow emission, dependent on composition and
size
High resistance to photo bleaching: inorganic particles are more
photostable than organic molecules and can survive longer
irradiation times
Long fluorescence lifetime: fluorescent of quantum dots are 15
to 20 ns, which is higher than typical organic dye lifetimes.
Improved detection sensitivity: inorganic semiconductor
nanoparticles can be characterized with electron microscopes
58
59. Quantum Dots
• Raw quantum dots are toxic
• But they fluoresce brilliantly, better than dyes
(imaging agents)
• Only way of clearance of protected QDs from the body
is by slow filtration and excretion through the kidney
60.
61. Quantum Dots
QD technology helps cancer researchers to observe fundamental
molecular events occurring in the tumor cells by tracking the
QDs of different sizes and thus different colors, tagged to
multiple different biomoleules, in vitro by fluorescent
microscopy.
QD technology holds a great potential for applications in
nanobiotechnology and medical diagnostics where QDs could be
used as labels.
62. Quantum Dots for Imaging of Tumor Cells
Figure 2. Phase contrast images (top row) and
fluorescence image NIH-3T3 cells incubated with QDs2;
(c) SKOV3 cells were incubated with QDs2
FPP-QDs specifically bind to tumor cells via the membrane expression of
FA receptors on cell surface
Y. Zhao et al. Journal of Colloid and Interface Science 350 (2010) 44–50. 62
63. Quantum dots conjugated with folate–PEG–PMAM
for targeting tumor cells
Folate–poly(ethylene glycol)–polyamidoamine ligands encapsulate and solubilize
CdSe/ZnS quantum dots and target folate receptors in tumor cells.
Dendrimer ligands with multivalent amino groups can react with Zn2+ on the surface
of CdSe/ZnS QDs based on direct ligand-exchange reactions with ODA ligands
Y. Zhao et al. Journal of Colloid and Interface Science 350 (2010) 44–50. 63
64.
65. Nano-particulate pharmaceuticals
Brand name
Emend
(Merck & Co. Inc.)
Rapamune
(Wyeth-Ayerst Laboratories)
Abraxane
(American Biosciences, Inc.)
Rexin-G
(Epeius Biotechnology
corporation)
Olay Moisturizers
(Procter and Gamble)
Trimetaspheres (Luna Nanoworks)
Description
Nanocrystal (antiemetic) in a capsule
Silcryst
(Nucryst Pharmaceuticals)
Nano-balls
(Univ. of South Florida)
Enhance the solubility and sustained release of silver
nanocrystals
Nano-sized plastic spheres with drugs (active against
methicillin-resistant staph (MRSA) bacteria) chemically
bonded to their surface that allow the drug to be dissolved
in water.
Nanocrystallized Rapamycin (immunosuppressant) in a
tablet
Paclitaxel (anticancer drug)- bound albumin particles
A retroviral vector carrying cytotoxic gene
Contains added transparent, better protecting nano zinc
oxide particles
MRI images
66. Company Product
CytImmune Gold nanoparticles for targeted delivery of drugs to tumors
Nucryst
Antimicrobial wound dressings using silver nanocrystals
Nanobiotix Nanoparticles that target tumor cells, when irradiated by xrays the
nanoparticles generate electrons which cause localized destruction of the tumor cells.
Oxonica
Disease identification using gold nanoparticles (biomarkers)
Nanotherapeutics Nanoparticles for improving the performance of drug delivery by
oral, inhaled or nasal methods
NanoBio
Nanoemulsions for nasal delivery to fight viruses (such as the flu and
colds) and bacteria
BioDelivery Sciences Oral drug delivery of drugs encapuslated in a nanocrystalline
structure called a cochleate
NanoBioMagnetics
Magnetically responsive nanoparticles for targeted drug
delivery and other applications
Z-Medica
Medical gauze containing aluminosilicate nanoparticles which help bood
clot faster in open wounds.
68. Open Problems
Manufacturing NPs for medical use:
Putting the drug on the particle
Maintaining the drug in the particle
Making the drug come off the
particle once application is done
Purity and homogeneity of
nanoparticles
SOLUTION:
Assessment of NPs:
Dynamic structural
features in vivo
Kinetics of drug
release
Triggered drug release
69. Open Problems
Toxicity:
short term - no toxicity in animals
long term- not known
Toxicity for both the host and the environment should be addressed
70. Open Problems
Delivery:
Ensuring Delivery to target
organ/cell
Removal of nanoparticles
from the body
SOLUTION:
detection of NPs
at target, organs
, cells
, subcellular
location et al.
Tissue
distribution
71. Open Problems:
Targeting the brain
• Brain micro-vessel endothelial cells build
up the blood brain barrier (BBB)
• The BBB hinders water soluble molecules
and those with MW > 500 from getting into
the brain
73. Open Problems
GMP Challenges
• No standards for:
Purity and homogeneity of nanoparticles
Manufacturing Methods
Testing and Validation
74. Summary
• Toxicities of nanomaterials are unknown
• to best target the nanomaterials so that systemic
administration can be used
• to uncage the drug so it gets out at the desired
location
• to “re-cage” the drug when it is no longer desired
• Removal of nanoparticles from the body
• Mathematical modeling of nanostructures
• Barrier crossing (BBB, G.I., et al.)